Literature DB >> 2200947

The comparative responses of Salmonella typhimurium TA1537 and TA97a to a range of reference mutagens and novel compounds.

M R O'Donovan1.   

Abstract

Salmonella typhimurium TA97a was added to the set of indicator strains routinely used for the Ames test in this laboratory (TA1535, TA1537, TA1538, TA98 and TA100) for a trial period during which a total of approximately 40 reference mutagens and novel pharmaceutical compounds were examined. The conclusions from this trial were as follows: (i) there are agents mutagenic for TA1537 which are not detected by TA97a. (ii) except for agents requiring the R factor plasmid, TA97a shows no increased sensitivity to mutagens when compared with TA1537 and (iii) nearly all the limited published database is for the original isolate, TA97, rather than TA97a, and the results obtained here indicate significant differences in response between the two; TA97a remains, therefore, essentially unvalidated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200947     DOI: 10.1093/mutage/5.3.267

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  3 in total

1.  Mutagenicity of cytostatic drugs in a bacterial system. I. Ames test.

Authors:  J Marhan
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

2.  The strains recommended for use in the bacterial reverse mutation test (OECD guideline 471) can be certified as non-genetically modified organisms.

Authors:  Kei-Ichi Sugiyama; Masami Yamada; Takumi Awogi; Atsushi Hakura
Journal:  Genes Environ       Date:  2016-01-22

Review 3.  A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests.

Authors:  Qianying Liu; Zhixin Lei; Feng Zhu; Awais Ihsan; Xu Wang; Zonghui Yuan
Journal:  Front Public Health       Date:  2017-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.